Free Trial

Aimia (AIM) Competitors

Aimia logo
C$3.18 -0.04 (-1.24%)
As of 08/14/2025 04:00 PM Eastern

AIM vs. CRON, TLRY, SLS, TEV, ABT, NOT, PYR, NVO, DNA, and VBV

Should you be buying Aimia stock or one of its competitors? The main competitors of Aimia include Cronos Group (CRON), Tilray Brands (TLRY), Solaris Resources (SLS), Tervita (TEV), Absolute Software Co. (ABT.TO) (ABT), Noront Resources (NOT), PyroGenesis Canada Inc. (PYR.V) (PYR), Novo Resources Corp. (NVO.V) (NVO), Dalradian Resources (DNA), and VBI Vaccines (VBV). These companies are all part of the "pharmaceutical products" industry.

Aimia vs. Its Competitors

Cronos Group (TSE:CRON) and Aimia (TSE:AIM) are both small-cap pharmaceutical products companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, valuation, risk, institutional ownership, media sentiment, earnings, analyst recommendations and dividends.

In the previous week, Aimia had 2 more articles in the media than Cronos Group. MarketBeat recorded 2 mentions for Aimia and 0 mentions for Cronos Group. Aimia's average media sentiment score of 0.06 beat Cronos Group's score of 0.00 indicating that Aimia is being referred to more favorably in the news media.

Company Overall Sentiment
Cronos Group Neutral
Aimia Neutral

Cronos Group has a beta of 1.02, suggesting that its stock price is 2% more volatile than the S&P 500. Comparatively, Aimia has a beta of 0.95, suggesting that its stock price is 5% less volatile than the S&P 500.

16.0% of Cronos Group shares are held by institutional investors. Comparatively, 31.6% of Aimia shares are held by institutional investors. 46.4% of Cronos Group shares are held by company insiders. Comparatively, 3.3% of Aimia shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Aimia has a consensus target price of C$4.00, suggesting a potential upside of 25.79%. Given Aimia's stronger consensus rating and higher possible upside, analysts clearly believe Aimia is more favorable than Cronos Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cronos Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Aimia
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Aimia has a net margin of -16.96% compared to Cronos Group's net margin of -42.65%. Cronos Group's return on equity of -4.40% beat Aimia's return on equity.

Company Net Margins Return on Equity Return on Assets
Cronos Group-42.65% -4.40% -3.73%
Aimia -16.96%-14.38%-4.93%

Cronos Group has higher earnings, but lower revenue than Aimia. Cronos Group is trading at a lower price-to-earnings ratio than Aimia, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cronos GroupC$76.86M11.92-C$32.78M-C$0.18-19.31
AimiaC$464.71M0.66-C$78.81M-C$0.81-3.91

Summary

Aimia beats Cronos Group on 9 of the 16 factors compared between the two stocks.

Get Aimia News Delivered to You Automatically

Sign up to receive the latest news and ratings for AIM and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AIM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AIM vs. The Competition

MetricAimiaAsset Management IndustryFinancial SectorTSE Exchange
Market CapC$305.84MC$1.31BC$6.47BC$6.38B
Dividend Yield33.90%4.40%4.18%6.72%
P/E Ratio-3.9122.5714.2866.98
Price / Sales0.662,567.351,862.321,564.00
Price / Cash0.5160.71127.1483.29
Price / Book0.551.425.204.86
Net Income-C$78.81MC$265.04MC$1.23BC$301.20M
7 Day Performance2.91%0.38%0.97%1.07%
1 Month Performance6.00%0.84%2.52%2.35%
1 Year Performance20.91%7.18%28.48%27.93%

Aimia Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AIM
Aimia
2.5021 of 5 stars
C$3.18
-1.2%
C$4.00
+25.8%
+20.9%C$305.84MC$464.71M-3.9120News Coverage
CRON
Cronos Group
N/AC$3.53
-3.3%
N/A+7.1%C$932.15MC$76.86M-19.64450Gap Down
High Trading Volume
TLRY
Tilray Brands
N/AC$1.32
+3.9%
N/A-38.5%C$850.57MC$610.34M-3.192,650News Coverage
Gap Down
High Trading Volume
SLS
Solaris Resources
1.4474 of 5 stars
C$7.18
-2.3%
C$12.50
+74.1%
+145.0%C$823.65MN/A-12.5110News Coverage
High Trading Volume
TEV
Tervita
N/AN/AN/AN/AC$672.00MC$1.36B-645.5636,800Gap Up
ABT
Absolute Software Co. (ABT.TO)
N/AN/AN/AN/AC$636.46MC$104.67M63.42115,000High Trading Volume
NOT
Noront Resources
N/AC$1.10
-0.5%
N/A+0.0%C$612.18MN/A-7.20101,700
PYR
PyroGenesis Canada Inc. (PYR.V)
N/AC$3.85
+11.0%
N/A+0.0%C$606.96MC$6.01M-154.0090Gap Up
NVO
Novo Resources Corp. (NVO.V)
N/AC$2.38
-0.4%
N/A+0.0%C$548.24MN/A-21.2554,400
DNA
Dalradian Resources
N/AN/AN/AN/AC$519.02MN/A-56.15640
VBV
VBI Vaccines
N/AN/AN/AN/AC$308.86MC$3.36M-4.9722

Related Companies and Tools


This page (TSE:AIM) was last updated on 8/15/2025 by MarketBeat.com Staff
From Our Partners